PipelineReview.com (press release) Use caution when prescribing LIPTRUZET with a fenofibrate , and immediately discontinue both drugs if myopathy if diagnosed or suspected. Cases of myopathy, including rhabdomyolysis, have been reported with atorvastatin coadministered with colchicine, ...
Business Wire (press release) LIPTRUZET (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin , currently one...
Financial Mirror These decreases were partially offset by products sold in the first quarter of 2013 that were not sold in the first quarter of 2012, the largest of which was fenofibrate , the generic equivalent of TriCor®. European revenues of $873 million, an increase ...
Fort Mills Times These decreases were partially offset by products sold in the first quarter of 2013 that were not sold in the first quarter of 2012, the largest of which was fenofibrate , the generic equivalent of TriCor®. European revenues of $873 million, an increase ... and more »
Seeking Alpha Despite a significant decline on our partnered products, for example, the diltiazem CD and Adalat, which have significantly lower operating margins and hav...
Canada NewsWire (press release) The Company's first product is a fenofibrate formulation marketed in the United States as Lipofen®. Cipher's second product, an extended-release tramadol, is marketed in the United States as ConZipT and will be marketed in Canada as DurelaT. Cipher's ...
EON: Enhanced Online News (press release) UCERIS ( budesonide ) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis and ZEGERID (omeprazole/sodium bicarbonate) for the treatment of certain upper gastrointestinal disorders are ...
Laser Focus world ... which are indicated to treat type 2 diabetes; fenofibrate tablets under Fenoglide name that is used to treat primary hyperlipidemia or mixed dyslipidemia; and omeprazole /sodium bicarbonate capsules and powder for oral suspension under Zegerid name ...
